antibody therapy
Sponsors
St. Vincent Medical Center - Los Angeles, National Cancer Institute (NCI), Barbara Ann Karmanos Cancer Institute, University of Virginia, AIDS Malignancy Consortium
Conditions
AIDS-related LymphomaAdenocarcinoma of the PancreasAdult Non-Hodgkin's LymphomaAnaplastic Large Cell LymphomaLeukemiaLymphomaMetastatic Pancreatic AdenocarcinomaNHL
Phase 1
BL22 Immunotoxin in Treating Patients With Non-Hodgkin's Lymphoma or Chronic Lymphocytic Leukemia
WithdrawnNCT00024115
Updated: 2015-04-28
Monoclonal Antibody Therapy in Treating Patients With Advanced Solid Tumors
WithdrawnNCT00052403
Start: 2002-02-28Updated: 2014-01-16
Monoclonal Antibody Plus Cyclophosphamide in Treating Patients With Metastatic Cancer
NCT00002482
Start: 1991-06-30Updated: 2013-11-06
Safety Study of CAT-8015 Immunoxin in Patients With NHL With Advance Disease
NCT00515892
Start: 2007-08-31Target: 50Updated: 2007-08-14
BATS With in Combination With Low Dose IL-1 and GM-CSF for Advanced Pancreatic Cancer
CompletedNCT02620865
Start: 2015-12-31End: 2021-06-21Updated: 2023-05-15
Phase 2
Gemcitabine Hydrochloride With or Without Bevacizumab in Treating Patients Who Are Undergoing Surgery for Pancreatic Cancer
WithdrawnNCT00253526
Updated: 2015-04-28
Bortezomib and Rituximab in Treating Patients With Relapsed or Refractory B-Cell Non-Hodgkin's Lymphoma
TerminatedNCT00265928
Target: 46Updated: 2008-01-28
Combination Chemotherapy Followed by Rituximab and Yttrium Y 90 Ibritumomab Tiuxetan in Treating Patients With Relapsed or Refractory AIDS-Related Non-Hodgkin's Lymphoma
WithdrawnNCT00310128
Start: 2006-02-28Updated: 2016-02-03